PTBP1 Promotes Growth, Migration and Invasion of Cholangiocarcinoma Cells by Regulating mRNA Alternative Splicing
10.13865/j.cnki.cjbmb.2022.06.1058
- Author:
Jing ZHANG
1
;
Gang-Qiao ZHOU
1
;
Jing ZHANG
2
;
Peng-Bo CAO
2
;
Gang-Qiao ZHOU
2
;
Min CHENG
3
;
Gang-Qiao ZHOU
3
;
Qian JIN
4
Author Information
1. Department of Biology, School of Life Sciences, Hebei University
2. State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Institute of Radiation Medicine, Academy of Military Medical Sciences, Academy of Military Sciences
3. Department of Epidemiology, School of Public Health, Nanjing Medical University
4. Cancer Institute, Xuzhou Medical University
- Publication Type:Journal Article
- Keywords:
alternative splicing (AS);
cholangiocarcinoma (CCA);
GNAS;
polypyrimidine tract-binding protein 1 (PTBP1);
RNA sequencing (RNA-seq);
TGIF1
- From:
Chinese Journal of Biochemistry and Molecular Biology
2022;38(7):899-910
- CountryChina
- Language:Chinese
-
Abstract:
Cholangiocarcinoma (CCA) is a highly invasive type of cancer with insidious onset and high mortality. Polypyrimidine tract-binding protein 1 (PTBP1) is highly over-expressed in various types of tumor tissues, which contributes to cancer progression. But the role of PTBP1 in CCA has not been explored yet. In this study, we aim to investigate the function of PTBP1 in CCA. Therefore, we used publicly available data from the cancer genome atlas (TCGA) to evaluate the dysregulation of PTBP1 in CCA. The results showed that the PTBP1 is significantly up-regulated in CCA tissues compared to the matched non-tumor tissues (P < 0. 05). We assessed the effects of PTBP1 on the growth of CCA cell lines RBE and HuH28 by performing CCK-8 and plate colony formation assays. The results showed that overexpression of PTBP1 significantly promoted the growth (P < 0. 01) of CCA cells, whereas knockdown of PTBP1 exhibited opposite effects. Transwell and Invasion assays revealed that overexpression of PTBP1 significantly promotes the migration and invasion of CCA cells (P < 0. 001), whereas knockdown of PTBP1 exhibited opposite effects (P < 0. 001). The RNA sequencing (RNA-seq) analysis in PTBP1-depleted cells showed that the up-regulated genes are significantly enriched in p53 signaling pathway, while the down-regulated genes are represented by cholesterol metabolism, Rho GTPase and TGF-β pathways. Then, the alternative splicing analysis revealed that inhibition of PTBP1 led to series of aberrant alternative splicing events, including several cancer-associated ones, such as splicing events within the TGF-β regulator TGIF1 and the p53 activity-correlated gene GNAS. These results indicate that PTBP1 promotes the progression of CCA likely by regulating the transcriptome alternative splicing to influence multiple cancer-associated signaling pathways.
